Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B-Reference-Cited by-同舟云学术

Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B

Published:2007-12-14 Issue:2 Volume:15 Page:85-93
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Fensterle J,Bergmann B,Yone C L R P,Hotz C,Meyer S R,Spreng S,Goebel W,Rapp U R,Gentschev I

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7701109.pdf

Reference51 articles.

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106–130.

2. Lilja H, Oldbring J, Rannevik G, Laurell CB . Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest 1987; 80: 281–285.

3. Oakley N . Clinical implications of prostate-specific antigen (PSA). Curr Opin Urol 1998; 8: 401–406.

4. Heiser A, Coleman D, Dannull J, Yancey D, Maurice MA, Lallas CD et al. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest 2002; 109: 409–417.

5. Barrou B, Benoit G, Ouldkaci M, Cussenot O, Salcedo M, Agrawal S et al. Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA. Cancer Immunol Immunother 2004; 53: 453–460.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The JMU-SalVac-System: A Novel, Versatile Approach to Oral Live Vaccine Development;Vaccines;2024-06-20

2. Exploiting bacteria for cancer immunotherapy;Nature Reviews Clinical Oncology;2024-06-05

3. Salmonella enterica and outer membrane vesicles are current and future options for cancer treatment;Frontiers in Cellular and Infection Microbiology;2023-12-05

4. Safety aspects of microorganisms deliberately released into the environment;EFB Bioeconomy Journal;2023-12

5. Bacteria-driven cancer therapy: Exploring advancements and challenges;Critical Reviews in Oncology/Hematology;2023-11